Free Submission Public Relations &
Deutsch English


Recently released market study: HIV / AIDS - Pipeline Review, H1 2013

Print article Print article
2013-03-31 12:48:51 - Recently published research from Global Markets Direct, "HIV / AIDS - Pipeline Review, H1 2013", is now available at Fast Market Research

Global Markets Direct's, 'HIV / AIDS - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for HIV / AIDS, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for HIV / AIDS. HIV / AIDS - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at

Note*: Certain sections in the report may be removed or altered based

on the availability and relevance of data for the indicated disease.


* A snapshot of the global therapeutic scenario for HIV / AIDS.
* A review of the HIV / AIDS products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the HIV / AIDS pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for HIV / AIDS.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding HIV / AIDS pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Global Markets Direct Report Coverage
HIV / AIDS Overview
Therapeutics Development
An Overview of Pipeline Products for HIV / AIDS
HIV / AIDS Therapeutics under Development by Companies
HIV / AIDS Therapeutics under Investigation by Universities/Institutes
HIV / AIDS Therapeutics - Products under Development by Companies
HIV / AIDS Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in HIV / AIDS Therapeutics Development
Bristol-Myers Squibb Company
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
Vical Incorporated
GlaxoSmithKline plc
Nektar Therapeutics
Inovio Biomedical Corporation
Gilead Sciences, Inc.
VIRxSYS Corporation
Merck & Co., Inc.
United Biomedical, Inc.
Lentigen Corporation
Myriad Genetics, Inc.
Sangamo BioSciences, Inc.
Cytokine PharmaSciences, Inc.
Generex Biotechnology Corporation
Nanotherapeutics, Inc.
Panacos Pharmaceuticals, Inc.
Isotechnika Pharma Inc.
Aphios Corporation
Achillion Pharmaceuticals, Inc.
Esteve Group
Pfizer Inc.
SuperGen, Inc.
Hadasit Medical Research Services & Development Ltd
Avexa Limited
Koronis Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals Inc.
Alfacell Corporation
Geron Corporation
GeoVax Labs, Inc.
Hemispherx Biopharma, Inc.
Hollis-Eden Pharmaceuticals, Inc.
Celldex Therapeutics, Inc.
iCo Therapeutics Inc.
Enzo Biochem, Inc.
Ardea Biosciences, Inc.
Medivir AB
Bio-Bridge Science, Inc.
Mymetics Corporation
NanoViricides, Inc.
Nutra Pharma Corporation
ConjuChem Biotechnologies Inc.
Critical Outcome Technologies Inc.
CytoGenix, Inc.
Immuron Limited
Cytos Biotechnology AG
Takara Bio Inc.
BioAlliance Pharma SA
Transgene Biotek Ltd
Narhex Life Sciences Limited
Paloma Pharmaceuticals, Inc.
Antigen Express, Inc.
Immune Network Research Ltd.
Functional Genetics, Inc.
BioClonetics Incorporated
Nutri Pharma ASA
BioMAS Ltd.
Vironova AB
ViroStatics, srl
Argos Therapeutics, Inc.
Cytheris SA
Altor BioScience Corporation
Proteologics, Inc.
PX'Therapeutics SA
Osel Inc.
Heat Biologics, Inc.
AiCuris GmbH & Co. KG
AlphaVax, Inc.
PTC Therapeutics, Inc.
Amplyx Pharmaceuticals, Inc.
Sequoia Pharmaceuticals, Inc.
Kineta, Inc.
Indus Biotech Private Limited
Presidio Pharmaceuticals, Inc.
Phage Biotechnology Corporation
Theraclone Sciences, Inc.
Frontier Biotechnologies, Inc.
Kainos Medicine, Inc.
Viral Genetics, Inc.
Wittycell S.A.S.
Concert Pharmaceuticals, Inc.
CytoDyn, Inc.
Immunotope, Inc.
GeneCure LLC
Omeros Corporation
ImmunoVaccine Technologies Inc.
Oncolys BioPharma Inc.
Globeimmune, Inc.
Etubics Corporation
Immunocore Limited.
Canopus BioPharma Incorporated
PepTcell Limited
TVAX Biomedical, LLC
Tobira Therapeutics, Inc.
Genetic Immunity, LLC
TNI Pharmaceuticals, Inc.
Medisyn Technologies, Inc.
Medestea Research & Production S.p.A.
Immunotech Laboratories, Inc.
Immunomic Therapeutics, Inc.
GeoVax, Inc.

Full Table of Contents is available at:

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact